Akso Health Group (AHG)

Cash Flow Statement (Annual)

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	2020	2019	2018	2017	2016	2015	2014
Net Income	-34.83	-71.2	5.53	65.48	8.57	3.54	-0.35
Depreciation & Amortization	0.02	0.12	0.02	0.17	0.09	0.06	0.02
Share-Based Compensation	0.06	0.35	6.59	1.83	0	0	0
Other Operating Activities	44.81	12.45	-13.87	20.24	-0.47	3.43	2.92
Operating Cash Flow	10.06	-58.28	-1.73	87.72	8.19	7.03	2.59
Operating Cash Flow Growth	-	-	-	971.13%	16.57%	171.62%	-
Capital Expenditures	0	-0.19	-0	-0.46	-0.29	-0.12	-0.22
Change in Investments	0.41	17.57	-67.1	-27.17	0	0	0
Other Investing Activities	-0.41	-4.6	-1	0	0	0	0
Investing Cash Flow	-0	12.78	-68.11	-27.62	-0.29	-0.12	-0.22
Dividends Paid	0	0	-19.55	0	0	0	0
Share Issuance / Repurchase	0	-2.39	-0.16	43.27	2	0	0
Debt Issued / Paid	-9.07	-6.65	71.42	4.35	8.23	2.65	2.96
Other Financing Activities	0.04	7.49	-51.74	-0.1	-5.94	-2.41	-4.37
Financing Cash Flow	-9.04	-1.55	-0.03	47.52	4.29	0.24	-1.41
Net Cash Flow	4.2	-46.45	-75.25	113.39	11.41	6.86	0.95
Free Cash Flow	10.06	-58.47	-1.73	87.27	7.9	6.9	2.36
Free Cash Flow Growth	-	-	-	1004.37%	14.44%	192.27%	-
Free Cash Flow Margin	573.15%	-845.64%	-46.89%	81.36%	34.48%	58.05%	50.85%
Free Cash Flow Per Share	0.62	-3.60	-0.11	5.82	0.56	0.49	0.17

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).